Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives

被引：10

作者：

Chen, Jian-Jian ^{[1
]}

Jin, Zhi-Cheng ^{[1
]}

Zhong, Bin-Yan ^{[2
]}

Fan, Wenzhe ^{[3
]}

Zhang, Wei-Hua ^{[1
]}

Luo, Biao ^{[1
]}

Wang, Yu-Qing ^{[1
]}

Teng, Gao-Jun ^{[1
]}

Zhu, Hai-Dong ^{[1
]}

机构：

[1] Southeast Univ, Ctr Intervent Radiol & Vasc Surg, Zhongda Hosp, Dept Radiol,Med Sch, Nanjing 210009, Peoples R China

[2] Soochow Univ, Affiliated Hosp 1, Dept Intervent Radiol, Suzhou, Peoples R China

[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou, Peoples R China

来源：

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL | 2024年 / 12卷 / 02期

基金：

中国国家自然科学基金;

关键词：

combined modality therapy; hepatocellular carcinoma; immune checkpoint inhibitors; locoregional therapy; molecular targeted therapy; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; RANDOMIZED CONTROLLED-TRIAL; INTERNAL RADIATION-THERAPY; VEIN TUMOR THROMBOSIS; RADIOFREQUENCY ABLATION; TRANSARTERIAL CHEMOEMBOLIZATION; CONVENTIONAL CHEMOEMBOLIZATION; LIVER-TRANSPLANTATION; IRRADIATION STENT; ELUTING BEADS;

D O I：

10.1002/ueg2.12554

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Hepatocellular carcinoma (HCC) is one of the most common cancers and a leading cause of cancer-related mortality. Locoregional therapies (LRTs) play a crucial role in HCC management and are selectively adopted in real-world practice across various stages. Choosing the best form of LRTs depends on technical aspects, patient clinical status and tumour characteristics. Previous studies have consistently highlighted the efficacy of combining LRTs with molecular targeted agents in HCC treatment. Recent studies propose that integrating LRTs with immune checkpoint inhibitors and molecular targeted agents could provide substantial therapeutic benefits, a notion underpinned by both basic and clinical evidence. This review summarised the current landscape of LRTs in HCC and discussed the anticipated outcomes of combinations with immunotherapy regimens.

引用

页码：226 / 239

页数：14

共 100 条

[1] Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy [J].

Ahmed, Osman ;

Pillai, Anjana .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (11) :1733-1736

[2] A comparative histological evaluation of the ablations produced by microwave, cryotherapy and radiofrequency in the liver [J].

Bhardwaj, N. ;

Strickland, A. D. ;

Ahmad, F. ;

Atanesyan, L. ;

West, K. ;

Lloyd, D. M. .

PATHOLOGY, 2009, 41 (02) :168-172

[3]

Bureau of Medical Administration NHCotPsRoC, 2022, ZHONGHUA GAN ZANG BI, V30, p367 388

[4] Transarterial viroembolization improves the therapeutic efficacy of immune-excluded liver cancer: Three birds with one stone [J].

Cao, Yanyan ;

Xiong, Fu ;

Kan, Xuefeng ;

Guo, Xiaopeng ;

Ouyang, Tao ;

Wang, Runyang ;

Yang, Junhan ;

Cai, Linkang ;

Liu, Binlei ;

Liang, Bin ;

Zheng, Chuansheng .

PHARMACOLOGICAL RESEARCH, 2023, 187

[5] Radiofrequency ablation of hepatocellular carcinoma: Mono or multipolar? [J].

Cartier, Victoire ;

Boursier, Jerome ;

Lebigot, Jerome ;

Oberti, Frederic ;

Fouchard-Hubert, Isabelle ;

Aube, Christophe .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (03) :654-660

[6] Interventional therapy combined with immune checkpoint inhibitors: Emerging opportunities for cancer treatment in the era of immunotherapy [J].

Chang, Xiaofeng ;

Lu, Xiaofeng ;

Guo, Jinhe ;

Teng, Gao-Jun .

CANCER TREATMENT REVIEWS, 2019, 74 :49-60

[7] Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma [J].

Chen, Ching-Tso ;

Liu, Tsung-Hao ;

Shao, Yu-Yun ;

Liu, Kao-Lang ;

Liang, Po-Chin ;

Lin, Zhong-Zhe .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)

[8] A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma [J].

Chen, MS ;

Li, JQ ;

Zheng, Y ;

Guo, RP ;

Liang, HH ;

Zhang, YQ ;

Lin, XJ ;

Lau, WY .

ANNALS OF SURGERY, 2006, 243 (03) :321-328

[9] Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma [J].

Chew, Valerie ;

Lee, Yun Hua ;

Pan, Lu ;

Nasir, Nurul J. M. ;

Lim, Chun Jye ;

Chua, Camillus ;

Lai, Liyun ;

Hazirah, Sharifah Nur ;

Lim, Tony Kiat Hon ;

Goh, Brian K. P. ;

Chung, Alexander ;

Lo, Richard H. G. ;

Ng, David ;

Filarca, Rene L. F. ;

Albani, Salvatore ;

Chow, Pierce K. H. .

GUT, 2019, 68 (02) :335-346

[10] Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT) a single-arm, phase 2 trial [J].

Chiang, Chi Leung ;

Chiu, Keith Wan Hang ;

Chan, Kenneth Sik Kwan ;

Lee, Francis Ann Shing ;

Li, James Chun Bong ;

Wan, Catherine Wing Suet ;

Dai, Wing Chiu ;

Lam, Tai Chung ;

Chen, Wenqi ;

Wong, Natalie Sean Man ;

Cheung, Andy Lai Yin ;

Lee, Venus Wan Yan ;

Lau, Vince Wing Hang ;

El Helali, Aya ;

Man, Kwan ;

Kong, Feng Ming ;

Lo, Chung Mau ;

Chan, Albert Chi-Yan .

LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (02) :169-178

← 1 2 3 4 5 6 7 8 9 10 →